The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transition of molecular target agent therapy in advanced hepatocellular carcinoma: A multicenter, retrospective study.
 
Kazufumi Kobayashi
No Relationships to Disclose
 
Sadahisa Ogasawara
Honoraria - Bayer; Eisai; Lilly; Merck
Consulting or Advisory Role - AstraZeneca; Bayer; Chugai Pharma; Eisai; Lilly; Merck
Research Funding - Bayer; Eisai; Lilly
 
Aya Takahashi
No Relationships to Disclose
 
Yuya Seko
No Relationships to Disclose
 
Satoshi Tsuchiya
No Relationships to Disclose
 
Kenji Iwai
No Relationships to Disclose
 
Rui Sato
No Relationships to Disclose
 
Shunji Watanabe
No Relationships to Disclose
 
Keisuke Koroki
No Relationships to Disclose
 
Hiroaki Kanzaki
No Relationships to Disclose
 
Naoya Kanogawa
No Relationships to Disclose
 
Takayuki Kondo
No Relationships to Disclose
 
Eiichiro Suzuki
No Relationships to Disclose
 
Tetsuhiro Chiba
No Relationships to Disclose
 
Makoto Arai
No Relationships to Disclose
 
Michihisa Moriguchi
Consulting or Advisory Role - Bayer Yakuhin; Eisai; Lilly Japan
Speakers' Bureau - Bayer Yakuhin; Eisai; Lilly Japan
Research Funding - Eisai; Merck Sharp & Dohme
 
Naoki Morimoto
No Relationships to Disclose
 
Takeshi Aramaki
Speakers' Bureau - Chugai Pharma; Eisai; Lilly Japan; Taiho Pharmaceutical; TERUMO
 
Yoshito Itoh
Speakers' Bureau - Eisai; Merck Sharp & Dohme
Research Funding - Bayer Yakuhin; Eisai; Merck Sharp & Dohme
 
Naoya Kato
Honoraria - Bayer Yakuhin; Eisai; Lilly Japan
Consulting or Advisory Role - Bayer Yakuhin; Eisai; Lilly Japan
Research Funding - Bayer Yakuhin; Eisai; Lilly Japan; Takeda